Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 …

…, P Hau, C Marosi, J Sroubek, E Hovey… - The Lancet …, 2017 - thelancet.com
Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion
mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet …

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy …

…, T Powles, SLS Wong, TH Tan, EJ Hovey… - The Lancet, 2017 - thelancet.com
Background Few treatments with a distinct mechanism of action are available for patients with
platinum-refractory advanced or metastatic urothelial carcinoma. We assessed the efficacy …

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma

…, AK Nowak, L Cher, H Wheeler, EJ Hovey… - Neuro …, 2015 - academic.oup.com
Background The optimal use of bevacizumab in recurrent glioblastoma (GBM), including the
choice of monotherapy or combination therapy, remains uncertain. The purpose of this …

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer …

…, A Dowling, M George, L Horvath, E Hovey… - The Lancet …, 2023 - thelancet.com
Background The interim analysis of the ENZAMET trial of testosterone suppression plus
either enzalutamide or standard nonsteroidal antiandrogen therapy showed an early overall …

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy …

…, T Powles, SLS Wong, TH Tan, EJ Hovey… - The Lancet …, 2020 - thelancet.com
Background Ramucirumab—an IgG1 vascular endothelial growth factor receptor 2 antagonist—plus
docetaxel was previously reported to improve progression-free survival in platinum-…

The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross‐sectional study

…, P Grimison, GC Toner, M Stockler, E Hovey… - Psycho …, 2013 - Wiley Online Library
Objective This cross‐sectional study aimed to identify the prevalence and correlates of
supportive care needs in testicular cancer (TC) survivors. Methods Men who had completed …

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship …

…, P Grimison, GC Toner, MR Stockler, E Hovey… - Journal of Cancer …, 2016 - Springer
Purpose This study aimed to establish the prevalence, severity, and correlates of psychological
distress and impaired generic health-related quality of life (HRQOL) in testicular cancer (…

Implementing patient question-prompt lists into routine cancer care

A Dimoska, PN Butow, J Lynch, E Hovey, M Agar… - Patient education and …, 2012 - Elsevier
OBJECTIVE: To examine the feasibility and acceptability of routine provision of patient question
prompt lists (QPLs) to promote patient participation and patient–clinician communication …

Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma

…, T Shaw, MM Sinclair, L Miller, E Hovey… - Supportive Care in …, 2017 - Springer
Purpose This study aimed to determine how carer distress and psychological morbidity change
over time following a patient’s diagnosis of high-grade glioma (HGG) and identify factors …

[HTML][HTML] Screening for psychological distress in adult primary brain tumor patients and caregivers: considerations for cancer care coordination

…, D Legge, M Fleet, GK Simpson, E Hovey - Frontiers in …, 2015 - frontiersin.org
Introduction This study aimed to assess psychological distress (PD) as scored by the Distress
Thermometer (DT) in adult primary brain tumor patients and caregivers (CGs) in a clinic …